TransMedics Group, Inc. (TMDX) EV/Assets Ratio: 2.27x
Is TransMedics Group, Inc.’s EV/Assets ratio high or low?
TransMedics Group, Inc.'s EV/Assets ratio of 2.27x is 60% below its 5-year average of 5.68x, near the low end of its 5-year range (1.63x–13.43x).
As of Saturday, June 20, 2026. 57.89% below its 12-month average of 5.39x.
TMDX EV/Assets Ratio Chart
TMDX Average EV/Assets Ratio Chart
TMDX Current vs Average EV/Assets Ratio Chart
TMDX EV/Assets Ratio Metrics
EV/ASSETS RATIO
2.27x
EV/ASSETS RATIO AVG TTM
5.39x
EV/ASSETS RATIO AVG 3Y
4.92x
EV/ASSETS RATIO AVG 5Y
5.48x
EV/ASSETS RATIO AVG 10Y
N/A
EV/ASSETS RATIO AVG 15Y
N/A
EV/ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-57.89%
CURRENT VS 3Y AVG
-53.82%
CURRENT VS 5Y AVG
-58.55%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
TMDX Competitors' EV/Assets Ratio
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TransMedics Group, Inc. (TMDX) | $2.72B | 2.27x | 5.39x | 4.92x | 5.48x |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.07B | 0.80x | 0.81x | 0.99x | 1.12x |
| 23andMe Holding Co. (ME)vs › | $15.31M | 0.03x | 0.41x | 0.28x | 0.81x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.64B | 0.87x | 0.88x | 0.89x | 0.99x |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.91B | 3.97x | 5.68x | 7.30x | 5.77x |
| Tempus AI, Inc. (TEM)vs › | $8.87B | 4.63x | 6.19x | 7.84x | 7.84x |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.91B | 1.54x | 1.51x | 1.59x | 1.94x |
| Baxter International Inc. (BAX)vs › | $10.27B | 0.90x | 0.91x | 1.04x | 1.32x |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 0.56x | 0.52x | 0.58x | 0.69x |
| Revvity, Inc. (RVTY)vs › | $11.16B | 1.14x | 1.11x | 1.18x | 1.38x |
TransMedics Group, Inc. EV/Assets Ratio Formula & Definition
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
TransMedics Group, Inc. EV/Assets Ratio FAQ
- What is the EV/Assets ratio for TransMedics Group, Inc. (TMDX)?
- The EV/Assets ratio for TMDX stock is 2.27x.
- Is TransMedics Group, Inc.'s EV/Assets ratio high or low?
- TransMedics Group, Inc.'s EV/Assets ratio of 2.27x is 60% below its 5-year average of 5.68x, near the low end of its 5-year range (1.63x–13.43x).
- What is the TTM average EV/Assets ratio for TransMedics Group, Inc. (TMDX)?
- The TTM average EV/Assets ratio for TMDX stock is 5.39x.
- What is the 3Y average EV/Assets ratio for TransMedics Group, Inc. (TMDX)?
- The 3Y average EV/Assets ratio for TMDX stock is 4.92x.
- What is the 5Y average EV/Assets ratio for TransMedics Group, Inc. (TMDX)?
- The 5Y average EV/Assets ratio for TMDX stock is 5.48x.
TransMedics Group, Inc. EV/Assets Ratio History
| DATE | EV/ASSETS RATIO |
|---|---|
| 2026-06-18 | 2.27x |
| 2026-06-17 | 2.13x |
| 2026-06-16 | 2.19x |
| 2026-06-15 | 2.18x |
| 2026-06-12 | 2.12x |
| 2026-06-11 | 2.14x |
| 2026-06-10 | 2.17x |
| 2026-06-09 | 2.15x |
| 2026-06-08 | 2.07x |
| 2026-06-05 | 2.03x |
| 2026-06-04 | 2.08x |
| 2026-06-03 | 2.04x |
| 2026-06-02 | 2.01x |
| 2026-06-01 | 1.98x |
| 2026-05-29 | 1.98x |
| 2026-05-28 | 1.99x |
| 2026-05-27 | 2.05x |
| 2026-05-26 | 2.06x |
| 2026-05-22 | 2.02x |
| 2026-05-21 | 2.02x |
| 2026-05-20 | 2.00x |
| 2026-05-19 | 1.95x |
| 2026-05-18 | 2.00x |
| 2026-05-15 | 1.87x |
| 2026-05-14 | 1.84x |
| 2026-05-13 | 1.90x |
| 2026-05-12 | 1.89x |
| 2026-05-11 | 1.90x |
| 2026-05-08 | 1.99x |
| 2026-05-07 | 2.12x |
| 2026-05-06 | 2.12x |
| 2026-05-05 | 2.67x |
| 2026-05-04 | 3.70x |
| 2026-05-01 | 3.81x |
| 2026-04-30 | 3.84x |
| 2026-04-29 | 3.76x |
| 2026-04-28 | 3.86x |
| 2026-04-27 | 4.12x |
| 2026-04-24 | 4.23x |
| 2026-04-23 | 4.32x |
| 2026-04-22 | 4.37x |
| 2026-04-21 | 4.15x |
| 2026-04-20 | 4.32x |
| 2026-04-17 | 4.42x |
| 2026-04-16 | 4.16x |
| 2026-04-15 | 4.43x |
| 2026-04-14 | 4.41x |
| 2026-04-13 | 4.33x |
| 2026-04-10 | 4.35x |
| 2026-04-09 | 4.17x |
| 2026-04-08 | 4.17x |
| 2026-04-07 | 4.09x |
| 2026-04-06 | 4.00x |
| 2026-04-02 | 3.84x |
| 2026-04-01 | 3.83x |
| 2026-03-31 | 3.79x |
| 2026-03-30 | 3.60x |
| 2026-03-27 | 3.78x |
| 2026-03-26 | 3.90x |
| 2026-03-25 | 4.01x |
| 2026-03-24 | 4.16x |
| 2026-03-23 | 4.28x |
| 2026-03-20 | 4.35x |
| 2026-03-19 | 4.34x |
| 2026-03-18 | 4.32x |
| 2026-03-17 | 4.76x |
| 2026-03-16 | 4.76x |
| 2026-03-13 | 4.71x |
| 2026-03-12 | 4.63x |
| 2026-03-11 | 4.92x |
| 2026-03-10 | 5.00x |
| 2026-03-09 | 5.15x |
| 2026-03-06 | 4.95x |
| 2026-03-05 | 5.35x |
| 2026-03-04 | 5.64x |
| 2026-03-03 | 5.65x |
| 2026-03-02 | 5.61x |
| 2026-02-27 | 5.55x |
| 2026-02-26 | 5.14x |
| 2026-02-25 | 5.03x |
| 2026-02-24 | 5.26x |
| 2026-02-23 | 5.86x |
| 2026-02-20 | 5.84x |
| 2026-02-19 | 5.78x |
| 2026-02-18 | 5.89x |
| 2026-02-17 | 5.82x |
| 2026-02-13 | 5.65x |
| 2026-02-12 | 5.59x |
| 2026-02-11 | 5.80x |
| 2026-02-10 | 6.06x |
| 2026-02-09 | 5.93x |
| 2026-02-06 | 5.87x |
| 2026-02-05 | 5.64x |
| 2026-02-04 | 5.67x |
| 2026-02-03 | 5.90x |
| 2026-02-02 | 5.83x |
| 2026-01-30 | 5.83x |
| 2026-01-29 | 6.04x |
| 2026-01-28 | 6.13x |
| 2026-01-27 | 6.02x |
| 2026-01-26 | 6.06x |
| 2026-01-23 | 5.88x |
| 2026-01-22 | 6.00x |
| 2026-01-21 | 5.82x |
| 2026-01-20 | 6.17x |
| 2026-01-16 | 6.23x |
| 2026-01-15 | 6.25x |
| 2026-01-14 | 6.17x |
| 2026-01-13 | 6.20x |
| 2026-01-12 | 5.86x |
| 2026-01-09 | 5.96x |
| 2026-01-08 | 5.98x |
| 2026-01-07 | 5.97x |
| 2026-01-06 | 5.77x |
| 2026-01-05 | 5.50x |
| 2026-01-02 | 5.34x |
| 2025-12-31 | 5.30x |
| 2025-12-30 | 5.31x |
| 2025-12-29 | 5.36x |
| 2025-12-26 | 5.41x |
| 2025-12-24 | 5.53x |
| 2025-12-23 | 5.58x |
| 2025-12-22 | 5.63x |
| 2025-12-19 | 5.56x |
| 2025-12-18 | 5.27x |
| 2025-12-17 | 5.31x |
| 2025-12-16 | 5.44x |
| 2025-12-15 | 5.36x |
| 2025-12-12 | 5.52x |
| 2025-12-11 | 5.55x |
| 2025-12-10 | 5.71x |
| 2025-12-09 | 5.86x |
| 2025-12-08 | 5.94x |
| 2025-12-05 | 5.94x |
| 2025-12-04 | 6.03x |
| 2025-12-03 | 6.09x |
| 2025-12-02 | 6.16x |
| 2025-12-01 | 6.54x |
| 2025-11-28 | 6.36x |
| 2025-11-26 | 6.33x |
| 2025-11-25 | 6.34x |
| 2025-11-24 | 6.10x |
| 2025-11-21 | 5.70x |
| 2025-11-20 | 5.39x |
| 2025-11-19 | 5.81x |
| 2025-11-18 | 5.10x |
| 2025-11-17 | 4.94x |
| 2025-11-14 | 5.01x |
| 2025-11-13 | 5.03x |
| 2025-11-12 | 5.19x |
| 2025-11-11 | 5.32x |
| 2025-11-10 | 5.33x |
| 2025-11-07 | 5.19x |
| 2025-11-06 | 5.44x |
| 2025-11-05 | 5.42x |
| 2025-11-04 | 5.32x |
| 2025-11-03 | 5.43x |
| 2025-10-31 | 5.72x |
| 2025-10-30 | 5.91x |
| 2025-10-29 | 5.84x |
| 2025-10-28 | 6.04x |
| 2025-10-27 | 6.17x |
| 2025-10-24 | 6.08x |
| 2025-10-23 | 6.00x |
| 2025-10-22 | 5.58x |
| 2025-10-21 | 5.60x |
| 2025-10-20 | 5.59x |
| 2025-10-17 | 5.49x |
| 2025-10-16 | 5.40x |
| 2025-10-15 | 5.26x |
| 2025-10-14 | 5.20x |
| 2025-10-13 | 5.22x |
| 2025-10-10 | 5.02x |
| 2025-10-09 | 5.28x |
| 2025-10-08 | 5.51x |
| 2025-10-07 | 5.38x |
| 2025-10-06 | 5.32x |
| 2025-10-03 | 5.40x |
| 2025-10-02 | 5.42x |
| 2025-10-01 | 5.37x |
| 2025-09-30 | 5.24x |
| 2025-09-29 | 5.26x |
| 2025-09-26 | 5.32x |
| 2025-09-25 | 5.32x |
| 2025-09-24 | 5.48x |
| 2025-09-23 | 5.62x |
| 2025-09-22 | 5.83x |
| 2025-09-19 | 5.70x |
| 2025-09-18 | 5.65x |
| 2025-09-17 | 5.59x |
| 2025-09-16 | 5.56x |
| 2025-09-15 | 5.34x |
| 2025-09-12 | 5.35x |
| 2025-09-11 | 5.46x |
| 2025-09-10 | 5.04x |
| 2025-09-09 | 5.06x |
| 2025-09-08 | 4.94x |
| 2025-09-05 | 4.87x |
| 2025-09-04 | 4.87x |
| 2025-09-03 | 5.00x |
| 2025-09-02 | 5.21x |
| 2025-08-29 | 5.37x |
| 2025-08-28 | 5.45x |
| 2025-08-27 | 5.48x |
| 2025-08-26 | 5.38x |
| 2025-08-25 | 5.37x |
| 2025-08-22 | 5.59x |
| 2025-08-21 | 5.54x |
| 2025-08-20 | 5.68x |
| 2025-08-19 | 5.72x |
| 2025-08-18 | 5.86x |
| 2025-08-15 | 5.94x |
| 2025-08-14 | 6.04x |
| 2025-08-13 | 6.15x |
| 2025-08-12 | 6.11x |
| 2025-08-11 | 5.93x |
| 2025-08-08 | 5.35x |
| 2025-08-07 | 5.42x |
| 2025-08-06 | 5.54x |
| 2025-08-05 | 5.86x |
| 2025-08-04 | 5.99x |
| 2025-08-01 | 5.62x |
| 2025-07-31 | 5.55x |
| 2025-07-30 | 5.04x |
| 2025-07-29 | 5.24x |
| 2025-07-28 | 5.26x |
| 2025-07-25 | 5.40x |
| 2025-07-24 | 5.34x |
| 2025-07-23 | 5.49x |
| 2025-07-22 | 5.28x |
| 2025-07-21 | 5.19x |
| 2025-07-18 | 5.49x |
| 2025-07-17 | 5.61x |
| 2025-07-16 | 5.65x |
| 2025-07-15 | 5.76x |
| 2025-07-14 | 5.82x |
| 2025-07-11 | 5.61x |
| 2025-07-10 | 6.20x |
| 2025-07-09 | 6.27x |
| 2025-07-08 | 6.19x |
| 2025-07-07 | 6.21x |
| 2025-07-03 | 6.41x |
| 2025-07-02 | 6.33x |
| 2025-07-01 | 6.45x |
| 2025-06-30 | 6.64x |
| 2025-06-27 | 6.51x |
| 2025-06-26 | 6.45x |
| 2025-06-25 | 6.38x |
| 2025-06-24 | 6.57x |
| 2025-06-23 | 6.33x |
| 2025-06-20 | 6.14x |
| 2025-06-18 | 6.16x |
| 2025-06-17 | 6.74x |
| 2025-06-16 | 7.01x |
| 2025-06-13 | 7.06x |
| 2025-06-12 | 7.07x |
| 2025-06-11 | 7.06x |
| 2025-06-10 | 6.96x |
| 2025-06-09 | 6.89x |
| 2025-06-06 | 6.88x |
Showing the most recent 260 of 1,793 data points. The chart above shows the full history.
Related Metrics
About TransMedics Group, Inc.
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Waleed H. Hassanein